Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype

Blood

Volumn 88, Issue 11, 1996, Pages 4296-4303

  Ben Yehuda, Dina ^a   Krichevsky, Svetlana ^b   Caspi, Offer ^b   Rund, Deborah ^b   Polliack, Aaron ^b   Abeliovich, Dvora ^b   Zelig, Orly ^b   Yahalom, Vered ^b   Paltiel, Ora ^b   Or, Reuven ^b   Peretz, Tamar ^b   Ben Neriah, Susana ^b   Yehuda, Orly ^b   Rachmilewitz, Eliezer A ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; GYRASE INHIBITOR; MICROSATELLITE DNA; PROTEIN P53; RHODAMINE 123;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MUTATOR GENE; MYELODYSPLASTIC SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SURVIVAL TIME;

EID: 10544255085     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.11.4296.4296     Document Type: Article

References (38)

1. Balen KK, Antin JH: Treatment of therapy related acute myelogenous leukemia and myelodysplastic syndromes. Hematol Oncol Clin North Am 7:477, 1993
2. van Leeuwen FE, Chorus AMJ, van den Bell-Dusebout AW, Hagenbeek A, Noyon R, van Kerhoff EHM, Pinedo HM, Somers R: Leukemia risk following Hodgkin's disease: Relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. J Clin Oncol 12:1063, 1994
3. Swerdlow AJ, Douglas AJ, Vaughan Hudson G, Vaughan Hudson B, MacLennan KA: Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: Relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy. Br J Cancer 68:1006, 1993
4. Foss Abrahamsen J, Andersen A, Hannisdal E, Nome O, Foss Abrahamsen A, Kvaloy S, Host H: Second malignancies after treatment of Hodgkin's disease: The influence of treatment, follow-up time and age. J Clin Oncol 11:255, 1993
5. Murphy SB: Secondary acute myeloid leukemia following treatment with epipodophyllotoxins. J Clin Oncol 11:199, 1993
6. Pedersen-Bjergaad J, Philip P: Two different classes of therapy-related and de-novo AML? Cancer Genet Cytogenet 55:119, 1991
7. Rubin CM, Arthur DC, Woods WG, Lange BJ, Nowell PC, Rowley JD, Nachman J, Bostron B, Baum ES, Suarez CR, Shoh NR, Morgan E, Maurer HS, McKenzie SE, Larson RA, Le Beau MM: Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: Correlation between chromosomal abnormalities and prior therapy. Blood 78:2982, 1991
8. Carbone P, Santoro A, Giglio MC, Mitro S, Graanata G, and Barbata G: Cytogenetic findings in secondary acute nonlymphocytic leukemia. Cancer Genet Cytogenet 58:18, 1992
9. Whang-Peng J, Young RC, Lee EC, Longo DL, Schechter GP, DeVita VT: Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. Blood 71:403, 1988
10. Gillis S, Sofer O, Dan E, Zelig O, Ben-Yehuda D, Isackson R, Ben-Basat I, Rachmilewitz EA, Polliack A: Secondary t(15; 17) APL after treatment of Hodgkin's disease. Ann Oncol 6:777, 1995
11. Shulman LN: The biology of alkylating-agent cellular injury. Hematol Oncol Clin North Am 7:325, 1993
12. Little JB: Cellular, molecular, and carcinogenic effects of radiation. Hematol Oncol Clin North Am 7:337, 1993
13. Culotta E, Koshland DE: p53 sweeps through cancer research. Science 262:1958, 1993
14. Prokocimer M, Rotter V: Structure and function of p53 in normal cells and their aberrations in cancer cells: Projection on the hematologic cell lineage. Blood 84:2391, 1994
15. Michaeli J, Lerer I, Rachmilewitz EA, Fibach E: Stimulation of proliferation of human myeloid cells in culture: Application for cytogenetic analysis. Blood 68:790, 1986
16. Klinger HP: Rapid processing of primary embryonic tissues for chromosome banding pattern analysis. Cytogenet Cell Genet 11:424, 1972
17. Chaudhary PM, Roninson IB: Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85, 1991
18. Gutierrez MI, Bathia K, Siwarski D, Wolff L, Magrath IT, Mushinski FJ: Infrequent mutation in mouse tumors with deregulated myc. Cancer Res 52:1032, 1992
19. Honchel R, Halling KC, Schaid DJ, Pittelkow M, Thibodeau SN: Microsatellite instability in Muir-Torre syndrome. Cancer Res 54:1159, 1994
20. Toguehida J, McGree TL, Paterson JC, Eagle JR, Tucker S, Yandell DW, Dryja TP: Dinucleotide CA repeats in intron 2 of the RB gene. Genomics 17:535, 1993
21. Mutirangura A, Ledbetter SA, Kuwano A, Chinault AC, Ledbetter DH: Dinucleotide repeat polymorphism at the GABAn receptor b3 (GABRB3) locus in Angelman/Prader-Willi region (AS/PWS) of chromosome 15. Hum Mol Genet 1:67, 1992
22. Mhadevan C, Tsilfidis C, Sabourin L, Shutler B, Amemiya C, Jansen G, Neville C: Myotonic dystrophy mutation: An unstable CTG repeat in the 3′ untranslated region of the gene. Science 255:1253, 1992
23. Parsons R, Li GM, Longley M, Modrich P, Liu B, Berk T, Hamilton SR, Kinzler KW, Vogelstein B: Mismatch repair deficiency in phenotypically normal human cells. Science 268:738, 1995
24. Chillon M, Casals T, Mercier B, Bassas L, Lissens W, Silber S, Romey MC, Ruiz-Romero J, Verlingue C, Claustres M, Nunes V, Fereg C, Estival XE: Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. New Engl J Med 332:1475, 1995
25. Lerer I, Meiner V, Lavon I, Abeliovich D: Molecular diagnosis of Prader-Willi syndrome: Parent-of-origin dependent methylation sites and non-isotopic detection of (CA)n dinucleotide repeat polymorphisms. Am J Med Genet 52:79, 1994
26. Pritsche M, Haessler Ch, Brandner G: Induction of nuclear accumulation of the tumor suppressor protein p53 by DNA damaging agents. Oncogene 8:307, 1993
27. Hall PA, McKee PH, Menage Hdu P, Dover R, Lane DP: High levels of p53 protein in UV-irradiated normal human skin. Oncogene 8:203, 1993
28. Koeffler HP, Miller C, Nicolson MA, Ranyard J, Bosselman RA: Increased expression of p53 protein in human leukemia cells. Proc Natl Acad Sci USA 90:9075, 1993
29. Prokocimer M, Harris N, Brill E, Rotter V: Expression of p53 in human leukemia and lymphoma, in Gale RP, Golde DW (eds): Recent Advances in Leukemia and Lymphoma. New York, NY, Liss, 1987, p 143
30. Smith LJ, McCulloch EA, Benchimol S: Expression of the p53 oncogene in acute myeloblastic leukemia. J Exp Med 164:751, 1986
31. Jonveaux Ph, Fenaux P, Quiquandon I, Pignon JM, Lai JL, Loucheux-Lefebvre MH, Goosens M, Bauters F, Berger R: Mutations in p53 gene in myelodysplastic syndrome. Oncogene 6:2243, 1991
32. Sugimoto K, Hirano N, Toyoshima H, Chiba Sh, Mano H, Takaku F, Yazaki Y, Hirai H: Mutations in p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. Blood 81:3022, 1993
33. Gartenhaus R, Johns III MM, Wang P, Rai K, and Sidransky D: Mutator phenotype in a subset of chronic lymphocytic leukemia. Blood 87:38, 1996
34. Hemminki A, Peltomaki P, Mecklin JP, Jarvinen H, Salovaara R, Nystrom-Lahti M, de la Chapelle A, Aaltonen LA: Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nat Genet 8:405, 1994
35. Micolaldes NC, Papdopoulos N, Llu B, Wel YF, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Flelschmann RD, Fraser CM, Adams MD, Venter JC, Dunlop MG, Hamilton SR, Petersen GM, de la Chapelle A, Vogelstein B, Kinzler KW: Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371:75, 1994
36. Papadopoulos N, Nicolaides NC, Liu B, Parsons R, Lengauer C, Palombo F, D'Arrigo A, Markowitz S, Willson JKV, Kinzler KW, Jiricny J, Vogelstein B: Mutations in genetically unstable cells. Science 268:1915, 1995
37. Fishel R, Lescoe MK, Roa MRS, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027, 1993
38. Boyer JC, Umar A, Risinger JI, Lipford JR, Kane M, Yin S, Barrett JC, Kolondner RD, Kunkel TA: Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cells. Cancer Res 55:6063, 1995